Technical Analysis for ABT - Abbott Laboratories

Grade Last Price % Change Price Change
grade B 108.36 0.30% 0.32
ABT closed up 0.3 percent on Tuesday, October 20, 2020, on 71 percent of normal volume.
Earnings due: Oct 21
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Flat
Historical ABT trend table...

Date Alert Name Type % Chg
Cup with Handle Other 0.00%
Inside Day Range Contraction 0.00%
MACD Bearish Signal Line Cross Bearish 0.30%
Cup with Handle Other 0.30%
Multiple of Ten Bearish Other 0.30%
MACD Bullish Signal Line Cross Bullish -1.19%
Multiple of Ten Bearish Other -1.19%
MACD Bearish Signal Line Cross Bearish 0.97%
20 DMA Support Bullish 0.97%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.97%
Older End-of-Day Gignals for ABT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Trending on StockTwits about 9 hours ago
10 DMA Resistance about 9 hours ago
Rose Above 10 DMA about 14 hours ago
Up 1% about 14 hours ago
Down 1% 1 day ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, pain, fever, inflammation, hypothyroidism, gynecological disorders, intrahepatic cholestasis or depressive symptoms, physiological rhythm of the colon, dyslipidemia, and hypertension, as well as provides anti-infective and influenza vaccines. The company's Diagnostic Products segment provides diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; genomic-based tests; hematology systems and reagents; and diagnostic systems and tests for blood analysis, as well as instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents. Its Nutritional Products segment offers pediatric and adult nutritional products comprising various forms of prepared infant and follow-on formula. The company's Vascular Products segment provides coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular disease. Abbott Laboratories also offers blood glucose monitoring meters, test strips, and data management software and accessories for people with diabetes; and medical devices for the eye, including cataract surgery, LASIK surgery, contact lens care products, and dry eye products. The company primarily serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.
Medicine Cancer Life Sciences Pain Diabetes Inflammation Influenza Hypertension Cataract Health Care Products Irritable Bowel Syndrome Dyslipidemia Fever Cataract Surgery Generic Pharmaceuticals Vascular Disease Cholestasis Data Management Software Hypothyroidism

Is ABT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 114.195
52 Week Low 61.61
Average Volume 5,391,125
200-Day Moving Average 93.09
50-Day Moving Average 105.46
20-Day Moving Average 107.10
10-Day Moving Average 108.65
Average True Range 2.41
ADX 14.31
+DI 27.36
-DI 19.36
Chandelier Exit (Long, 3 ATRs ) 104.35
Chandelier Exit (Short, 3 ATRs ) 107.56
Upper Bollinger Band 112.11
Lower Bollinger Band 102.09
Percent B (%b) 0.63
BandWidth 9.36
MACD Line 1.02
MACD Signal Line 1.10
MACD Histogram -0.0762
Fundamentals Value
Market Cap 191.85 Billion
Num Shares 1.77 Billion
EPS 1.73
Price-to-Earnings (P/E) Ratio 62.60
Price-to-Sales 6.22
Price-to-Book 6.35
PEG Ratio 3.49
Dividend 1.44
Dividend Yield 1.33%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 111.03
Resistance 3 (R3) 111.24 110.57 110.59
Resistance 2 (R2) 110.57 109.89 110.46 110.44
Resistance 1 (R1) 109.46 109.47 110.02 109.25 110.29
Pivot Point 108.79 108.79 109.06 108.68 108.79
Support 1 (S1) 107.68 108.11 108.24 107.47 106.43
Support 2 (S2) 107.01 107.69 106.90 106.28
Support 3 (S3) 105.90 107.01 106.14
Support 4 (S4) 105.69